My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dyadic International, Inc. - Common Stock (NQ:DYAI)

1.100 -0.070 (-5.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dyadic International, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable Therapeutics 
From Dyadic International, Inc.
Via GlobeNewswire
Earnings Scheduled For November 12, 2024
 
Via Benzinga
Exploring Dyadic International's Earnings Expectations
 
Via Benzinga
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
From Dyadic International, Inc.
Via GlobeNewswire
Recap: Dyadic International Q4 Earnings
 
Via Benzinga
Dyadic Expands Global Presence with Participation in Key Industry Events
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
From Dyadic International, Inc.
Via GlobeNewswire
DYAI Stock Earnings: Dyadic International Misses EPS, Misses Revenue for Q2 2024
DYAI stock results show that Dyadic International missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
SmallCap Tech/Biotech Stocks July/Aug 2024: ZVSA, DYAI, ZVRA, PRSO, RLMD, VTAK, ENTO, INBS, KAVL
Via AB Newswire
Roaring Kitty Expands Horizons: Key Stocks to Watch as Influencer Shakes Up Market: CHWY, DYAI, WOOF, VTAK, INBS
Via AB Newswire
Dyadic Intl (NASDAQ: DYAI) and Proliant Health Biologicals to Launch $6 Billion Serum Albumin Market Product in 2025
Via AB Newswire
Topics Supply Chain
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
From Dyadic International, Inc.
Via GlobeNewswire
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress
Via AB Newswire
Topics Economy
GameStop Raises $2.14 Billion, Meme Stocks Buzz Fuels Gains Watch: GME, PRSO, DYAI, VTAK, AMC
Via AB Newswire
Spotlight June 2024: NASDAQ Stocks Under $2 Achieving Major Milestones TELL, DYAI, PRSO, SPEC, GME
Via AB Newswire
Topics Energy
Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX
Via AB Newswire
Dyadic International Inc. (NASDAQ: DYAI) Hits New 52-Week High Amidst Golden Cross, Bullish Swing Patterns and Bird Flu Concerns
Via AB Newswire
Peraso Inc. (NASDAQ: PRSO) Announces Paradigm-Shifting mmWave Wi-Fi Advancements with Phased Array Antenna Technology
Via AB Newswire
Dyadic to Attend Industry Events in June
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
Via AB Newswire
Dyadic (NASDAQ: DYAI) on “The Street Reports Podcast” COO Tackles the Food vs Fuel Debate
Via AB Newswire
Topics Climate Change
Top Stocks to Watch: FFIE, PLUG, SPWR, More Inside!
Via AB Newswire
DYAI Stock Earnings: Dyadic International Reported Results for Q1 2024
Dyadic International just reported results for the first quarter of 2024. 
Via InvestorPlace
Dyadic to Attend Industry and Investor Events in May
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
From Dyadic International, Inc.
Via GlobeNewswire
Discovering Undervalued Stocks in Today’s Market: OCGN, INBS, KAVL, DYAI, VTAK
Via AB Newswire
Exploring Stock Surges: Key Insights, Noteworthy BUZZ: KAVL, PRSO, DYAI, WISA, JAGX
Via AB Newswire
Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements
Via AB Newswire
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report
Via AB Newswire
Topics Regulatory Compliance
DYAI Stock Earnings: Dyadic International Misses EPS, Misses Revenue for Q4 2023
DYAI stock results show that Dyadic International missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.